Newscast cover image

Can Celeb Support Sign, Seal, Deliver Election Results?

Newscast

CHAPTER

Breakthrough in Alzheimer's Treatment

This chapter discusses the recent approval of Lecanumab, an Alzheimer's drug that has shown the ability to slow disease progression by 25%. It explores the implications for families, the challenges of diagnosis and treatment access, and the ongoing research into future treatments. The conversation also highlights personal stories and the balance between serious health discussions and lighter, more personal anecdotes.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner